| scholarly article | Q13442814 |
| P50 | author | Clarice Weinberg | Q89866315 |
| P2093 | author name string | D. A. Gilbert | |
| D. R. Saunders | |||
| F. E. Silverstein | |||
| A. D. Feld | |||
| D. Bergman | |||
| R. L. Sanford | |||
| P. Washington | |||
| C. M. Surawicz | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aspirin | Q18216 |
| prostaglandin E2 | Q416554 | ||
| P304 | page(s) | 339-345 | |
| P577 | publication date | 1984-02-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Prevention of acute aspirin-induced gastric mucosal injury by 15-R-15 methyl prostaglandin E2: an endoscopic study | |
| P478 | volume | 86 |
| Q70275649 | A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects |
| Q43240373 | Arbaprostil (15(R)-15-methyl PGE2): lack of effect on theophylline metabolism |
| Q68324593 | Aspirin-induced human antral injury is reduced by vodka pretreatment |
| Q69126486 | Cytoprotective doses of arbacet with minimal antisecretory properties are not effective in duodenal ulcer healing |
| Q52425733 | Effect of 15(R)-15-methyl PGE2 (arbaprostil) on duodenal bicarbonate secretion in rat. |
| Q47583181 | Effect of enprostil on amphibian gastroduodenal and human gastric bicarbonate secretion |
| Q68177324 | Effect of synthetic prostaglandin E1 analog (ornoprostil) on gastric emptying and pancreatic polypeptide release after solid-meal ingestion in man |
| Q93572160 | Gastric antisecretory activity of arbaprostil as affected by gastric pH |
| Q70275651 | Gastric protection by misoprostol against 1300 mg of aspirin. An endoscopic study |
| Q41737345 | Improving the gastrointestinal safety of NSAIDs: the development of misoprostol--from hypothesis to clinical practice |
| Q38627221 | Non-steroidal anti-inflammatory drug-induced gastropathy. Mechanisms and management |
| Q69846889 | Prostaglandins in pathophysiology of peptic ulcer disease |
| Q41345878 | Prostaglandins in peptic ulcer disease. An overview of current status and future directions |
| Q64914477 | Reduction of aspirin-induced fecal blood loss with low-dose misoprostol tablets in man. |
| Q43743417 | Reduction of endoscopically assessed acute aspirin-induced gastric mucosal injury with cimetidine |
| Q39633447 | Subepithelial hemorrhages and erosions of human stomach |
| Q93631210 | The pathophysiology of peptic ulcer disease |
| Q39498178 | Treatment of nonsteroidal antiinflammatory drug-induced gastric ulcers with misoprostol. A double-blind multicenter study |
Search more.